About METACyt

The Indiana Metabolomics and Cytomics Initiative (METACyt) is changing the way life sciences researchers at Indiana University Bloomington do science. Founded in 2004 with a $53 million grant from the Lilly Endowment, Inc., METACyt supports life sciences research at IUB with special emphasis on microbial systems, cell signaling and differentiation, analytical technology development, molecular neurosciences, and molecular and evolutionary biology. METACyt has helped IU researchers make important discoveries concerning:

• How ticks and mosquitoes spread disease
• How inflammation leads to heart disease
• The bacterial origin of the world’s strongest glue
• How the bacteria that cause pneumonia thrive in poor conditions
• How the genes of higher organisms are organized and read
• How humans and chimpanzees differ genetically

Discoveries made by METACyt researchers have already led to substantial advances in our understanding of living organisms and could lead to treatments for cancer, heart disease, and other ailments and to development of new adhesives for surgery and engineering.

Learn more:

• METACyt's economic development efforts
• How METACyt helps with research and collaboration
• METACyt contact information
• METACyt mailing list
• Current METACyt booklet (PDF)

Related links:

• Indiana Life Sciences Initiative
• Lilly Endowment, Inc.